After spending time at this year’s Self-Insurance Institute of America (SIIA) conference, one message came through clearly in nearly every carrier conversation I had: the stop loss market is no longer just hardening at the margins, it is fundamentally recalibrating.
Stop loss insurance is known as policies purchased by self-insured employers to protect themselves from unexpectedly high employee benefit health claims. It limits risk by capping liability and potentially reimbursing them for claims that may go over set amounts.
The shift has been coming for some time, but the discussions at SIIA helped clarify what is driving it and what it means for employers and partners going forward. After several consecutive years of soft market conditions, carriers are now responding to pressure from both the frequency and severity of large claims. The result is a renewed focus on underwriting discipline and a much lower tolerance for business that consistently underperforms.
For those of us operating day to day in the stop loss market, this is our reality. What stood out at SIIA was how openly carriers are acknowledging the need to change course and how closely their expectations now align with a more clinical, data‑driven approach to risk. In many ways, these conversations reinforced the direction our Avant Stop Loss team has taken in how we market accounts and how we support them after placement.
From Soft Market Conditions to Harder Decisions
During the soft market cycle, competition for stop loss business was intense. Capacity was plentiful, the pressure on pricing was constant, and many carriers were willing to stretch underwriting guidelines to maintain relationships or protect market shares. In some cases, business was knowingly priced thin or at a loss with the expectation that market conditions would eventually normalize.
That normalization is now happening.
Large claims are occurring more often, and when they occur, the dollar impact is significantly higher than what many blocks were designed to absorb. Oncology advances, specialty drugs, complex neonatal claims, and emerging therapies are no longer isolated scenarios; they are becoming recurring drivers of loss experience.
Carriers at SIIA’s Spring Exchange made it clear that this environment demands a different level of discipline. Many are now explicitly willing to walk away from groups that have become loss leaders or that carry unresolved or ongoing large claim exposure without a plan for management. This is not about short‑term rate corrections. It reflects a structural reset in how stop loss risk is evaluated.
Underwriting is More Intentional Again
One of the strongest themes across carrier discussions was the return to medical underwriting fundamentals. Underwriters want more clarity, context, and confidence heading into renewal decisions.
High‑level claims summaries are no longer enough on their own. Carriers want to understand what drives claims, where care is delivered, which networks and providers are involved, and what treatment protocols are ahead. By asking better questions, we can expect partners to bring equally thoughtful answers.
This shift favors employers who are actively managing their risk and partners who can translate complex clinical and claims data into a credible narrative. It also reinforces a reality that is sometimes overlooked: stop loss is not just an annual purchase. It’s an ongoing risk management strategy that requires coordination across clinical, financial, and administrative functions throughout the year.
Why Clinical Strategy Has Become Central
The conversations I had at SIIA further validated something we have believed for a long time—in a hardening market, the most effective lever is not aggressive marketing: it’s insight.
The ability to identify large claimants of concern early, often before they cross traditional high‑cost thresholds, allows employers to be proactive with their risk rather than reactive at renewal time. Understanding not only who the claimant is, but also where care is being delivered, how that care compares to best‑practice standards, and what future treatment will look like can change the entire conversation.
At Avant, our clinical team works alongside underwriting and analytics partners to project large claim exposure with real precision, down to geography, network affiliation, and provider patterns. This level of detail supports more meaningful discussions with carriers. Instead of uncertainty, underwriters receive objective information about what is happening currently, and what is likely to happen next.
Context like this matters. When carriers understand that claims are being actively monitored and that treatment plans have been reviewed clinically, it influences how risk is priced and whether capacity remains available.
Partnering With Carriers, Not Just Submitting Data
Another clear takeaway from SIIA was how much carriers value collaboration. In a hardening market, simply delivering data and waiting for quotes is no longer a viable strategy.
Underwriters want transparent conversations. They want partners who can explain the story behind the numbers, outline mitigation strategies, and demonstrate that risk is being managed intentionally, not passively. Providing credible insight into upcoming treatment protocols, intervention strategies, and network optimization helps underwriters move from cautious defensiveness to informed decision‑making.
This approach does not eliminate renewal increases. Market pressures are real, and carriers must price accordingly. It allows employers who invest in clinical oversight and large claimant mitigation strategies to experience below market average increases year over year, even as the broader market hardens.
What This Means for Employers
The hardening of the stop loss market should not be viewed as a reason to abandon self‑funding. In fact, it reinforces why self‑funding remains attractive when paired with the right risk management strategy.
Employers who treat stop loss as a commodity are likely to feel the full force of the market. Those who view it as part of an integrated approach to managing healthcare risk will remain better positioned. That means investing in clinical insight, engaging consistently throughout the year, and working with teams that can bring clarity to complex data.
The message from SIIA was clear: carriers are looking for partners who understand risk deeply and manage it proactively. Those relationships are becoming more valuable as underwriting discipline increases.
Move Forward With Stop Loss Strategy
The stop loss market is changing because the risk has changed. For employers and advisors alike, the path forward is not to resist that shift, but to meet it with a better strategy.
Clinical‑led insight, early identification of risk, and transparent collaboration with underwriting partners are essential. When all those pieces are in place, even a hardening market can be navigated successfully. That reality is not a headwind—it’s an opportunity to do this work the right way.
At Avant, we support stop loss insurance with disciplined procurement, strong carrier negotiations, and ongoing support to ensure your business has strategic advantage you need to succeed. Reach out today to learn more about our core capabilities.
Let’s route you to the right specialist.
Tell us what you’re working on and we’ll connect you with the right team—quickly.
